Fair Value Measurement (Restated) (Tables)
|
12 Months Ended |
Dec. 31, 2021 |
|---|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis |
The following tables present the Company’s fair value hierarchy for its financial instruments that are measured at fair value on a recurring basis:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Long-term liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Public warrants |
|
$ |
5,060 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
5,060 |
|
Private Placement warrants |
|
|
— |
|
|
|
6,422 |
|
|
|
— |
|
|
|
6,422 |
|
Contingent Earnout liability |
|
|
— |
|
|
|
— |
|
|
|
10,026 |
|
|
|
10,026 |
|
|
|
$ |
5,060 |
|
|
$ |
6,422 |
|
|
$ |
10,026 |
|
|
$ |
21,508 |
|
|
|
December 31, 2020 |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Long-term liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
EIB warrant liability |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
4,007 |
|
|
$ |
4,007 |
|
|
| Summary of Change in Fair Value of The Warrant Liabilities |
The following table provides a roll-forward of the aggregate fair values of the Level 3 financial instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contingent
Earnout
Liability |
|
|
Contingent
Interest
Embedded
Derivative |
|
|
Warrant
Liability |
|
Fair value at December 31, 2019 |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
197 |
|
Issuance of warrants to EIB |
|
|
— |
|
|
|
— |
|
|
|
3,612 |
|
Change in fair value |
|
|
— |
|
|
|
— |
|
|
|
198 |
|
Fair value at December 31, 2020 |
|
|
— |
|
|
|
— |
|
|
|
4,007 |
|
Issuance of warrants to Silicon Valley Bank |
|
|
— |
|
|
|
— |
|
|
|
308 |
|
Conversion of Silicon Valley Bank warrants to common stock |
|
|
— |
|
|
|
— |
|
|
|
(308 |
) |
Exercise of Series C preferred warrants |
|
|
— |
|
|
|
— |
|
|
|
(891 |
) |
Contingent interest embedded derivative recognized relating to the FP Term Loan agreement |
|
|
— |
|
|
|
8,922 |
|
|
|
— |
|
Contingent interest embedded derivative derecognized upon the execution of the FP amendment |
|
|
— |
|
|
|
(8,922 |
) |
|
|
— |
|
Contingent earnout liability recognized upon the closing of the reverse recapitalization |
|
|
58,274 |
|
|
|
— |
|
|
|
— |
|
Change in fair value of contingent earnout liability |
|
|
(48,248 |
) |
|
|
— |
|
|
|
— |
|
Change in fair value included in other income (expense), net |
|
|
— |
|
|
|
— |
|
|
|
19,466 |
|
Transferred to Level 2 upon the closing of the reverse recapitalization |
|
|
— |
|
|
|
— |
|
|
|
(22,582 |
) |
Fair value at December 31, 2021 |
|
$ |
10,026 |
|
|
$ |
— |
|
|
$ |
— |
|
|
| Summary of Warrants Classified as Equity That Are Measured at Fair Value on Nonrecurring Basis |
The following tables present the Company’s fair value hierarchy for its warrants classified as equity that are measured at fair value on a nonrecurring basis:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Equity: |
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
970 |
|
|
$ |
970 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2020 |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Equity: |
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
970 |
|
|
$ |
970 |
|
|
| Private Warrants [Member] |
|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Schedule of Quantitative Information Regarding Warrant Liability |
The table below quantifies the significant inputs used for the Private Warrants:
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
August 16, |
|
|
|
2021 |
|
|
2021 |
|
Fair value of the Company’s common stock |
|
$ |
3.38 |
|
|
$ |
9.93 |
|
Exercise price |
|
$ |
11.50 |
|
|
$ |
11.50 |
|
Risk-free interest rate |
|
|
1.26 |
% |
|
|
0.75 |
% |
Expected volatility factor |
|
|
70.0 |
% |
|
|
22.0 |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
Remaining contractual term (in years) |
|
|
4.6 |
|
|
|
5.0 |
|
|
| E I B Warrants [Member] |
|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Schedule of Quantitative Information Regarding Warrant Liability |
In November 2021, EIB warrants were settled for a cash amount of $19,942. As of December 31, 2021 no EIB warrants remained outstanding. The table below quantifies the inputs used for the EIB warrants:
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
2021 |
|
|
2020 |
|
Fair value of the Company’s common stock |
|
$ |
— |
|
|
$ |
4.19 |
|
Risk-free interest rate |
|
|
— |
% |
|
|
0.13 |
% |
Expected volatility factor |
|
|
— |
% |
|
|
68.4 |
% |
Remaining contractual term (in years) |
|
|
— |
|
|
|
4.7 |
|
|
| Contingent Earnout Liability [Member] |
|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Schedule of Quantitative Information Regarding Warrant Liability |
The table below quantifies the significant inputs used for the Contingent Earnout Liability:
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
August 16, |
|
|
|
2021 |
|
|
2021 |
|
Fair value of the Company’s common stock |
|
$ |
3.38 |
|
|
$ |
9.93 |
|
Risk-free interest rate |
|
|
1.26 |
% |
|
|
0.75 |
% |
Expected volatility factor |
|
|
70.0 |
% |
|
|
70.0 |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
Remaining contractual term (in years) |
|
|
0.004 |
|
|
|
0.004 |
|
|